Pushkang, a leading provider of POCT products, utilizes centrifugal microfluidics as its core technology, focusing on critical illness detection and chronic disease management. The company has successfully developed a range of POCT products, including Coagulation, Biochemistry, Veterinary, and Hematology testing, catering to diverse healthcare settings such as laboratories, emergency departments, ICUs, medical nursing institutions, primary medical institutions, and mobile medical care scenarios.

Committed to innovation and improving healthcare outcomes, Pushkang continues to expand its technology platform，which aims to contribute to the realization of the "Healthy China 2030" strategic goal, and in response to the call of the "One Belt, One Road" initiative. driving positive changes in healthcare delivery and management.  Pushkang's continuous efforts position it as a key player in advancing POCT technology and positively impacting patient care.